ImmunityBio (IBRX) Property, Plant & Equipment (Net) (2014 - 2026)
Powered by 
Analysis
ImmunityBio (IBRX) Property, Plant & Equipment (Net) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 107.22 Mn |
| 10 | ImmunityBio | 8.48 Bn | 8.12 Bn | 50.94 Mn | 114.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.22 Mn |
| Mar 31, 2026 | 112.79 Mn |
| Dec 31, 2025 | 114.26 Mn |
| Sep 30, 2025 | 129.60 Mn |
| Jun 30, 2025 | 133.00 Mn |
| Mar 31, 2025 | 135.27 Mn |
| Dec 31, 2024 | 137.09 Mn |
| Sep 30, 2024 | 139.29 Mn |
| Jun 30, 2024 | 141.96 Mn |
| Mar 31, 2024 | 143.52 Mn |
| Dec 31, 2023 | 146.08 Mn |
| Sep 30, 2023 | 152.00 Mn |
| Jun 30, 2023 | 151.49 Mn |
| Mar 31, 2023 | 154.17 Mn |
| Dec 31, 2022 | 143.66 Mn |
| Sep 30, 2022 | 130.44 Mn |
| Jun 30, 2022 | 119.45 Mn |
| Mar 31, 2022 | 105.22 Mn |
| Dec 31, 2021 | 82.86 Mn |
| Sep 30, 2021 | 69.88 Mn |